Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)

Clinical trial NCT06721871 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06721871
Sponsor: Napo Pharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Microvillus Inclusion Disease Congenital Disorders Rare Diseases

Start date: 2025-05-01
Primary completion: 2026-12-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.